首页> 外文期刊>Journal of Huazhong University of Science and Technology >Construtcion of Neisseria Gonorrhoeae Porin B Plasmid Recombinant and Its Expression in E. coli
【24h】

Construtcion of Neisseria Gonorrhoeae Porin B Plasmid Recombinant and Its Expression in E. coli

机译:淋病奈瑟氏菌孔蛋白B质粒重组的构建及其在大肠杆菌中的表达

获取原文
获取原文并翻译 | 示例
           

摘要

A prokaryotic expression recombinant plasmid pET-PIB to express porin B (PIB) of Neisseria gonorrhoeas in E. coli DE_3 was constructed in order to provide a basis of research in detection, prophylactic and therapeutic vaccine against the pathogen infection. The gene encoding PIB was amplified by PCR from Neisseria gonorrhoeas and cloned into prokaryotic expression plasmid pET-28a( + ) to construct a pET-PIB recombinant, which was verified by restriction endonuclease and DNA sequencing. Protein PIB was expressed in E. coli DE_3 induced with IPTG. The antigenici-ty of the expressed protein was evaluated by indirect ELISA. Rabbits were immunized with the protein and serum was collected after immunization. To assess the immunogenicity of the protein, the liter of serum to protein PIB was determined by ELISA. DNA sequence analysis showed that the nucleic acid sequence of PIB gene was 99. 28 % of homology compared with that (NGPIB18) published in GenBank. A 41 kD fused protein was detected by SDS-PAGE and was proven to have reactivity with anti-PIB polyclonal antibody from mouse. A polyclonal antibody to PIB of 1:4000 titer determined by indirect ELISA was obtained from rabbit immunized with the purified product. Recombinant plasmid encoding PIB of Neisseria gonorrhoeas was constructed. Protein PIB with anti-genicity and immunogenicity was successfully expressed.
机译:构建了在大肠杆菌DE_3中表达淋病奈瑟氏球菌的蛋白B(PIB)的原核表达重组质粒pET-PIB,为针对病原体感染的检测,预防和治疗疫苗研究提供了基础。通过PCR从淋病奈瑟氏球菌中扩增出编码PIB的基因,并将其克隆到原核表达质粒pET-28a(+)中,构建了pET-PIB重组体,并通过限制性内切酶和DNA测序对其进行了验证。蛋白PIB在IPTG诱导的大肠杆菌DE_3中表达。通过间接ELISA评估表达的蛋白质的抗原性。用蛋白免疫兔子,并在免疫后收集血清。为了评估蛋白质的免疫原性,通过ELISA确定了血清对蛋白质PIB的升数。 DNA序列分析表明,PIB基因的核酸序列与GenBank上发表的(NGPIB18)具有99. 28%的同源性。通过SDS-PAGE检测到41kD融合蛋白,并证明与小鼠抗PIB多克隆抗体具有反应性。通过间接ELISA确定的针对PIB的多克隆抗体为1:4000滴度,是从用纯化产物免疫的兔子中获得的。构建了编码淋病奈瑟氏球菌PIB的重组质粒。具有抗原性和免疫原性的蛋白PIB被成功表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号